We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$772M
2
LLY icon
Eli Lilly
LLY
+$337M
3
LULU icon
lululemon athletica
LULU
+$301M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$297M
5
RMD icon
ResMed
RMD
+$273M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$576M
2
T icon
AT&T
T
+$476M
3
PNC icon
PNC Financial Services
PNC
+$393M
4
FTV icon
Fortive
FTV
+$389M
5
ACN icon
Accenture
ACN
+$374M

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGLY icon
10551
CALL
Singularity Future Technology
SGLY
$4.41M
$204K ﹤0.01%
481
-123
-20% -$101K
SLYG icon
10552
CALL
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.26B
$204K ﹤0.01%
+2,900
New +$220K
WWW icon
10553
CALL
Wolverine World Wide
WWW
$1.73B
$204K ﹤0.01%
+10,100
New +$209K
AAMI
10554
CALL
Acadian Asset Management
AAMI
$3.28B
$204K ﹤0.01%
11,300
-8,700
-44% -$178K
HLGN
10555
CALL
DELISTED
Heliogen, Inc.
HLGN
$204K ﹤0.01%
2,760
+206
+8% +$26.8K
NSR
10556
DELISTED
Nomad Royalty Company Ltd.
NSR
$204K ﹤0.01%
+28,962
New +$223K
EFO icon
10557
ProShares Ultra MSCI EAFE
EFO
$29.6M
$203K ﹤0.01%
+6,116
New +$236K
FLWS icon
10558
PUT
1-800-Flowers.com
FLWS
$262M
$203K ﹤0.01%
21,300
-39,500
-65% -$436K
HYFM icon
10559
PUT
Hydrofarm Holdings
HYFM
$7M
$203K ﹤0.01%
5,830
-5,780
-50% -$470K
DFTX
10560
CALL
Definium Therapeutics
DFTX
$5.73B
$203K ﹤0.01%
21,147
+627
+3% +$7.93K
RWAY icon
10561
Runway Growth Finance
RWAY
$290M
$203K ﹤0.01%
17,986
+4,385
+32% +$58.2K
SGU icon
10562
PUT
Star Group
SGU
$415M
$203K ﹤0.01%
+22,100
New +$228K
WBX
10563
CALL
Wallbox
WBX
$75.2M
$203K ﹤0.01%
1,145
-1,755
-61% -$377K
BIOR
10564
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$203K ﹤0.01%
1,158
-724
-38% -$153K
LUNA
10565
CALL
DELISTED
Luna Innovations Incorporated
LUNA
$203K ﹤0.01%
+34,900
New +$206K
JUN.U
10566
DELISTED
Juniper II Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
JUN.U
$203K ﹤0.01%
20,258
-555
-3% -$5.61K
AVPT icon
10567
PUT
AvePoint
AVPT
$2.85B
$202K ﹤0.01%
46,600
-4,100
-8% -$20.8K
CAPR icon
10568
CALL
Capricor Therapeutics
CAPR
$386M
$202K ﹤0.01%
57,800
-16,800
-23% -$59.6K
CXM icon
10569
PUT
Sprinklr
CXM
$1.61B
$202K ﹤0.01%
20,000
-20,500
-51% -$249K
E icon
10570
PUT
ENI
E
$79.8B
$202K ﹤0.01%
8,500
-900
-10% -$25.7K
FOCL
10571
EDAP TMS S.A.
FOCL
$178M
$202K ﹤0.01%
+29,698
New +$206K
FTDR icon
10572
CALL
Frontdoor
FTDR
$5.96B
$202K ﹤0.01%
8,400
-4,000
-32% -$108K
GFF icon
10573
CALL
Griffon
GFF
$4.72B
$202K ﹤0.01%
+7,200
New +$182K
IAI icon
10574
PUT
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
$202K ﹤0.01%
+2,400
New +$216K
JEPI icon
10575
JPMorgan Equity Premium Income ETF
JEPI
$46.3B
$202K ﹤0.01%
3,639
-18,555
-84% -$1.07M
421 422
423
424 425

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.